[MRNA] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[MRNA] Moderna, Inc.
Announcement Date
03-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -163.04%
YoY- -448.03%
Quarter Report
MRNA's Result
MRNA's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 1,831,000 3,220,000 4,829,000 12,216 13,338 36,662 42,473 87.19%
PBT -1,958,000 1,217,000 3,552,000 -232,772 -123,372 -80,331 -64,785 76.44%
Tax 1,672,000 174,000 219,000 864 -178 1,235 2 869.58%
NP -3,630,000 1,043,000 3,333,000 -233,636 -123,194 -80,331 -68,264 93.85%
Tax Rate - -14.30% -6.17% - - - - -
Total Cost 5,461,000 2,177,000 1,496,000 245,852 136,532 116,993 110,737 91.44%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -198.25 32.39 69.02 -1,912.54 -923.63 -219.11 -160.72 3.55%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -9.53 2.53 8.27 -0.59 -0.37 -0.25 -1.05 44.40%
EPS Diluted -9.53 2.53 7.70 -0.59 -0.37 -0.25 -1.05 44.40%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.